Related Experiment Video

Updated: Jun 12, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Aerosolized Delivery of Antifungal Agents

Jennifer Le, Daryl S Schiller

    Current Fungal Infection Reports
    |May 27, 2010
    PubMed

    Insights

    Aerosolized antifungal delivery shows promise for preventing pulmonary fungal infections in immunocompromised patients, but current evidence is limited and routine use is not recommended. Further research is needed to confirm its therapeutic role and safety.

    Area of Science:

    • Pulmonology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Pulmonary Aspergillus infections pose significant risks for immunocompromised individuals.
    • Systemic antifungal agents are standard treatment, but aerosolized delivery offers localized drug concentration with reduced systemic exposure for prevention.
    • Current evidence for aerosolized antifungals in prevention is mainly for amphotericin B, with other agents under investigation.

    Purpose of the Study:

    • To review aerosolized delivery systems for antifungal agents.
    • To discuss intrapulmonary pharmacokinetics of inhaled antifungals.
    • To summarize clinical findings on aerosolized antifungal use in preventing pulmonary fungal infections.

    Main Methods:

    • Literature review of aerosolized delivery systems.
    • Analysis of pharmacokinetic data for inhaled antifungal drugs.
    • Evaluation of clinical trial results for aerosolized antifungal prevention strategies.

    Main Results:

    • Conflicting clinical trial results exist for various amphotericin B formulations.
    • Routine use of aerosolized delivery for fungal infection prevention is not currently recommended.
    • Other antifungal agents like itraconazole, voriconazole, and caspofungin are being investigated for aerosolized delivery.

    Conclusions:

    • Aerosolized delivery is a potential strategy for preventing pulmonary fungal infections, particularly in high-risk populations.
    • Insufficient high-quality clinical evidence currently supports routine use of aerosolized antifungals.
    • Well-designed clinical trials are essential to determine the efficacy, safety, and optimal use of aerosolized antifungal agents.

    More Related Videos

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals04:22

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

    Published on: March 30, 2017

    Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products06:47

    Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products

    Published on: December 5, 2020

    Related Concept Videos

    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
    Drug Delivery: Miscellaneous Routes01:22

    Drug Delivery: Miscellaneous Routes

    Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
    Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
    Transdermal patches transport drugs through the...
    Inhaled Medications01:23

    Inhaled Medications

    Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
    Additional Routes of Drug Administration01:18

    Additional Routes of Drug Administration

    Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
    Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Transmission-based Precautions II: Airborne and Protective Environment01:25

    Transmission-based Precautions II: Airborne and Protective Environment

    Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
    Airborne precautions:
    Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...